Berkshire’s Cash Bulk… And New Data In The Weight Loss Drug Race 11/4/24

4 Nov 2024 · 44 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Podcast Summary: "Fast Money" - Berkshire’s Cash Bulk… And New Data In The Weight Loss Drug Race (11/4/24)

Episode Overview In this episode of CNBC's "Fast Money," hosted by Brian Sullivan, the discussion centers around Warren Buffett’s Berkshire Hathaway reducing its stake in Apple, the implications for investors, and new developments in the weight loss drug sector, particularly concerning Viking Therapeutics.

Key Discussion Points

Berkshire Hathaway's Stake in Apple

  • Position Reduction:
  • Berkshire Hathaway has decreased its stake in Apple to less than $70 billion, significantly down from the earlier position at the start of the year.
  • Discussion on whether Buffett is selling to raise funds for a new opportunity or if he perceives less value in Apple.
  • Market Performance:
  • Apple's stock is up 15% in 2024, but underperforms compared to other tech giants like NVIDIA and Meta.
  • Investor Sentiment:
  • The traders debate whether Buffett's actions serve as a warning to other investors.
  • Tim Seymour emphasizes that 13F filings are backward-looking and not indicative of future performance.
  • Concern arises over rising interest rates impacting banks, with significant sales of Bank of America shares also noted.
  • Cash Reserves:
  • Berkshire currently holds over $325 billion in cash, prompting speculation about future investment strategies.
  • The consensus suggests that Buffett's selling is part of a strategic repositioning rather than a panic exit.

Market Positioning Ahead of Elections

  • Impact of Elections on Markets:
  • The team discusses the current volatility in bond markets, correlating it with upcoming elections.
  • Jim Bianco of Bianco Research mentions that the recent volatility in bond rates is partly driven by election expectations and potential fiscal stimulus.
  • Inflation Concerns:
  • Discussion on potential inflationary pressures and how a change in political leadership might influence fiscal policies.

Viking Therapeutics and Weight Loss Drug Developments

  • Market Reaction:
  • Viking Therapeutics' stock initially surged following positive data on a weight loss drug but ultimately fell by 13%.
  • Analyst opinions suggest the initial excitement may have been tempered by competitive pressures from other firms like AstraZeneca.
  • Investor Strategy:
  • Jared Holes from Mizuho advises traders to identify leading stocks in the obesity treatment space, suggesting a mix of established and emerging biotech firms.

Semiconductor Sector Update

  • NXP Semiconductor Earnings:
  • NXP shares decline after underwhelming guidance influenced by macroeconomic conditions.
  • Market Sentiment:
  • Traders express caution and highlight the need for a clearer outlook post-election as it relates to the automotive sector and semiconductor demand.

Key Takeaways

  • Berkshire Hathaway's Strategy:
  • Buffett's strategic selling of Apple shares sparks a broader discussion about value investing and market timing.
  • Market Volatility:
  • The upcoming elections are anticipated to create increased volatility in both equity and bond markets.
  • Weight Loss Drug Race:
  • The competitive landscape in the obesity drug market is heating up, with multiple players vying for market share, which may create investment opportunities but also risks.
  • Semiconductor Sector Challenges:
  • Macro headwinds continue to impact semiconductor stocks, necessitating a close watch on their performance in light of political and economic developments.

Conclusion This episode of "Fast Money" navigates the complexities of current investment landscapes shaped by major market players' strategies, upcoming elections, and evolving sectors such as biotech and semiconductors. The insights offered by the expert traders provide valuable perspectives for investors looking to make informed decisions amidst market fluctuations.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:01Live from the NASDAQ market side in the heart of New York City's Times Square. This is Fast Money, and here's what's on tap tonight. Bad Apple, the Oracle of Omaha slashing Berkshire Hathaway's stake in the iPhone maker. So if Warren Buffett is selling, should you be too? Nuclear troubles. The energy company's breaking down today after regulators nixing a big deal in the space. What is next for the names, and is there more trouble to come there? Plus, how markets are positioning ahead of the election. Viking Therapeutics on its way down on some bad obesity drug news. and the chart master goes panning for gold.

0:38Is he placing his bets on the precious metal or on the miners? Well, you're going to have to stick around to find out. That's why we call it a tease. Hi, everybody. I am Brian in for Melissa once again, coming to you live from Studio B, the NASDAQ, and on your desk tonight, Tim Seymour, Courtney Garcia, Carter Worth, and Steve Grasso all physically around the table. I love it because we are going to start with a potential warning sign for the Oracle of Omaha, Warren Buffett's Berkshire Hathaway, further cutting its position in Apple in the third quarter. It still holds a lot, but it's now under $70 billion.

1:15That's a lot of money, but it is less than half the stake that they held at the beginning of the year. Now, there's really two ways to look at this. Shares of Apple, they're up 15 % in 2024, underperforming a lot of the mega cap stocks and the S &P, but still a pretty good return In fact, if we look at it in the Mag 7, Apple ranks number five. NVIDIA, Meta, Alphabet, Amazon all posting better returns. So it kind of, Tim, begs the question, is he selling to just raise money for something else? Is he selling because he still owns a ton? And if he is selling, him or his team, we don't actually know if it's like Warren Buffett, like, filling out a form.

1:54Just call it Warren. Filling out a form. Good enough. Right? Probably sure he signs off on it. Is that a sign for the rest of our viewers and listeners? Well, what we always say on this show is that 13 Fs are backward looking. And so there's an element of this that really should not be how we're focused on anything. And what Warren was focused on in the third quarter, well, we're now in the fourth quarter. And it's a dynamic that I think is always fascinating. Warren is known as a value investor. So when you hear of an investor who thinks that the intrinsic value in stocks is essentially gone, you know, that that's something to listen to, because, again, this is where Warren has really made his money.

2:31And everybody knows the numbers on the outperformance to the S &P. The other dynamic that I think is what has investors most nervous is who was best positioned in the financial crisis to scoop up preferred chairs of Goldman Sachs, Mars, Bank of America. And again, you know, he he the form fours that he's filing because he owns more than 10 percent of Bank of America are part of what have people very concerned. I would make an argument it's a combination of truly being a value investor and seeing a lot less value in some of the names. The selling in Bank of America is more interesting to me on some level because this is a position that's almost down 25 percent from where it was even a couple of quarters ago.

3:08And it's a case where I think there's some concern that the rates, the rate cuts that the Fed will be bringing will be very poor for banks. So I'm not you know, I don't think any investor should be rushing to to the door based upon. I mean, the the Apple selling we've been hearing about for months. And this is critical, Steve, to remember about Warren Buffett. Warren Buffett is not considered the greatest investor ever because he buys high and sells low. He hoards cash. They have over 320. Warren Buffett has more money than most nation states right now. And what he does is he wants to raise money.

3:45So when he sees an extraordinary and rare opportunity, he buys in. So are we taking anything away from the sale of Apple? Maybe he just wants the money for something else. Well, he's in short-term treasuries right now. He's got$325 billion, but he's not buying back his own stock. Right. Right. So I think that's the biggest takeaway. So if Apple is not the bargain, his own stock's not the bargain right now. There's no bargains. So to your point, are there bargains in the market? No. Maybe some people, I look at you because I think that you probably don't think that there's a lot of bargains, so I apologize.

4:18There's always something to buy. But one of the great investors of all time is making a decision to not buy. Right. And he's had plenty of cash before the current trimming, right? So now it's getting to be in an unbelievably large pile of cash. And there's also cap gains tax. That could be changing, too. There's volatility around the market. And maybe he wants Greg Abel to make his own decisions on what he wants to do with the money. So that's where you start off. We don't know who's making the decision to sell it, but maybe they just want to be sitting on a ton until they find something that's worthwhile.

4:49And we never I mean, not never, Courtney, but I know. Listen, there's there's an inherent bias that we have on CNBC. I fully admit that. Say, when do we buy something? When do we buy something? We very rarely ask the question. You guys do a great job of it here. But I mean, you know, I see what I did there, which is when do we sell something? And let's not forget, he still owns over$60 billion in Apple. So what do you take away from this? Yeah, and I think that's something, I don't think you want to take this as a negative on Apple. He's not exiting his position by any means. If it went to zero, we might have to have a different conversation.

5:21That would be a completely different conversation, but that's not where we're at. And he has been taking this off the table this year. And I think really Berkshire Hathaway had become mostly Apple and cash, which is kind of interesting because that's where the markets were, a lot of investors are either in the MAG-7 or in cash. but he really has always made sure he's a diversified portfolio. He's constantly pounding the table about that. And so I think seeing him take some profits here is more going to be for the future opportunities. What those are, I think, is the question. That's what we're all trying to figure out is what is he going to do with that cash?

5:49That we're going to need some answers on, but I don't think this is a bad thing on Apple. And the stock itself, of course, it dipped today quite substantially, but it's just in line with the insurance stock. If you look at his beta or his correlation to the S &P, it's actually higher to the transports and it's even higher to the S &P 500 insurance sub-industry group. So it really is treated as an insurer. And most of them have dipped of late. You look at MetLife. You look at Allstate. So I think you buy the dip. Yeah. And to your point, Steve Grasso, Warren Buffett has a whole team. You mentioned a few, Todd, and there's Gray and whatever.

6:25You just wonder, like, let the kids run. I mean, I say kids are probably in their mid 50s, but you get my point. Let them do what they want with the 325 plus this extra. It's all relative. Every year it gets a little more relative. You get my point. Let them run. Right. Warren Buffett's in his mid 90s. You're going to have to let your predecessors do their job. He defined his running of Berkshire the way he wanted to run it, the stocks that he wanted to buy, the sectors that he wanted to get involved with. And to your point, he's got to let the next generation figure out. So we don't. But again, Tim, do we take this away as everybody sell everything of Apple because Warren Buffett sold some shares?

7:03Well, no. I mean, again, far be it from me. I'm not being critical of what Berkshire's done. And it's been a it's been a phenomenal performer. But but actually for the last eight quarters, I think their net, you know, 166 billion in selling. This has been arguably one of the greatest eight quarter runs in the S &P history. So, you know, you don't he's not a market timer. He's he's happy to be very early. And if he sees things out there and I get back to intrinsic value in stocks, it truly is, you know, an oversimplified version of intrinsic value is truly there is more value in the whole than it's trading at.

7:38He doesn't see that. He's a valuation guy. It doesn't surprise me that we're in the place we're in. It's not the reason to go out and sell Apple today. If anything, those headlines came out six months ago and we knew about that selling. $325 billion in cash. I mean, someone was going to get a headline like Warren Buffett buys Germany. He bought German stocks? No, no, he bought the country. He just bought Germany. It's undervalued. All right. For more on the markets, the Fed, interest rates, and whatever else he wants to talk about, maybe Warren Buffett. Let's bring in Jim Bianco, Bianco Research.

8:06Jim, you can chime in on that if you want, but I want to start here. We have an election tomorrow. And without bringing politics into politics, let's bring politics into this because rates fell a few weeks ago. 10-year, 4.3 to 3.6, whatever it was, they've recently almost violently popped back up. And the stock market has moved with it. How much of that move in the bond and rate market is an expectation of a specific election outcome either way? I think only just the last couple of days to a week or so has really been about the election. And you see it in what's called the move index. It's kind of the VIX of the bond market.

8:47It's at a one-year high. Volatility in the bond market is through the roof. There's expectations that there's maybe fiscal stimulus coming or spending coming. But whatever the election means for the markets, it's being focused in on the bond market. And I think all the other markets are taking their reaction to it. And last thing is, look at Friday's move and look at today's move. These are extraordinarily large moves that we've seen in the bond market. But in this environment, they're just kind of average for what we're expecting through the rest of the week. Do you see another re-ignition of inflation either way?

9:2450 basis point rate cut took some people by surprise. You had some politicians today, very high profile ones, calling for more rate cuts. Neither candidate seems particularly concerned about debts or the deficits. Do you see inflation rearing its ugly head again in some form, Jim? Yeah, I do in 25. I think the problem with the 50 basis point cut was that it was a signal that the Fed, to put it in Austin Goolsbee's terms, the Chicago Fed president, they've got hundreds of basis points to cut rates through 2020 through the end of 2025. and you've seen what interest rates have done. Look at what mortgage rates have done.

10:04They've gone straight up since the middle of September, right after the Fed cut. And this is the market, I think, just screaming at the Fed, whoa, too much. You're going to create an inflation problem. You're going to overstimulate an economy that doesn't need this much stimulation. And if you throw in that a Trump victory, we'll find out in 24, 48 hours, that we're going to be looking at tax cuts, deregulation and tariffs, we definitely don't need hundreds of basis points of rate cuts over the next year or so. And I think that the bond market's just screaming that this is just too much, which is why you've seen interest rates, long-ender yields, go straight up.

10:43So, Jim, we really value your view here. And you're talking about a couple of different things. I mean, the fundamental view that the economy is not as weak as people had thought, as the market had thought, but obviously the deficit dynamics that I think we certainly all focus on here. There's a credit dynamic. There's an issuance dynamic. So there's technical elements. But I also hear you saying bonds look interesting and that actually, you know, in a world where we've had 20 plus percent returns in the S &P, there's other things to do. Where would you be in the bond market here? Because it sounds to me like you think rates could back up a little bit.

11:12I think there's a lot of investors that watch this show that have become Treasury market investors in the last couple of years and they've enjoyed it. And there's some fear of moving too far out on the rates curve. So where would you be? Well, yeah. You know, to put this into perspective, I'll channel my inner Dr. Jeremy Siegel. In his book, Stocks for the Long Run, the edition of last year, what should stocks return you from this moment forward? I know they've had two 20 % years already, but rational expectations are about a 6 % to 8 % return is on average what you should get. Well, if this is 2019, and you look at the bond market yielding somewhere between zero and two, we were screaming, Tina, there is an alternative.

11:53But this is late 2024, where the Bloomberg Aggregate Index is nearly 5%. You can get most of the expected returns out of the stock market with a lot less risk, because in a bond market, a bad year is like down 1 % or down 0 % or maybe up 1%. It's not a 20 % correction like we saw in 2022. And so I think that's why you've seen investors get very interested in the bond market. Bond ETFs have already set a yearly record in terms of their inflows. And they still got two months to go to add to it. So I think that if you want to look at what should you expect, I know most people expect 20 % a month, but they're not going to get that.

12:33But if you are in that gap that a 6%, 7%, 8 % return is reasonable, all of a sudden, if you look at the bond market, you could get the majority of that with a lot less risk. And that's why bonds are significant competition for the stock market right now. Jim Bianco, Bianco Research. Always appreciate your views and your straight talk, Jim. Thank you very much. I think Jim was saying 20 % a year, but you get her broader point. Is there a trade here in bonds or anywhere? Sounds like Jim might have been advising Warren Buffett, right? So Warren wanted an easier path, and 6 % to 8 % probably makes sense.

13:08And maybe Warren Buffett and maybe Jim are calling a top to the market, but it seems like the Fed doesn't want recessions anymore. It seems like they're trying to be so proactive that they don't want a recession. So they want to be early. I think they were late to cut, but it seems like there's a new Fed and a new sheriff in town. Who's that? I guess Powell. Because it's the same. But he's been the sheriff. Yeah, but he's a different dynamic. Meet the new boss. I think he is the same, Tim. Different dynamic. I don't know if we're going to get fooled again by this one. I think no one's going to fight the Fed.

13:42I think we're in a place here where I think the Fed's going 25 basis points. And I think the Fed's probably relieved that the economy, at least at this point, we know there are variable lags, et cetera, et cetera. But I do think that there is a fear that that inflation still could be out there. And we've just talked about all those risks. Good stuff. Let's move on to what's next. All right. From Wall Street to downtown D.C., security beefing up in the Capitol all ahead of Election Day tomorrow. Megan Gusella has more. Megan. Hey, Brian, that's right. We are here in downtown Washington right now, just a few blocks from the White House, where you can see businesses around me and apartment buildings behind me are gearing up for what they're worried could be a little bit of Election Day unrest here tomorrow.

14:23All weekend long, we've been seeing security going up, layers of security around the vice president's residence in northwest Washington, around the White House and the Treasury Department, and in the blocks surrounding the U.S. Capitol. And then over at Howard University, that's where Vice President Harris will be tomorrow night. There's also loads of security in place there. The city has asked all construction sites in that area to shut down and to remove anything from their sites that could be used as a projectile. So clearly lots of preparations being made here, Brian. But city officials are emphasizing that none of this is necessary, that there is no credible threat at this time of election violence, election day violence happening either here tomorrow or in the days later this week while we might still be waiting for a result.

15:03They've been trying to project really a sense of calm in the past few days and telling business leaders there is no need to board up like this, like you see around me. But in these blocks around the White House and downtown especially, business leaders aren't taking that advice. They're making the calculation that they would rather invest in these security measures than take the risk of damage to their storefronts. And, Brian, they lived through some unrest in the 2017 inauguration for Trump's first term, the 2020 summer protests, both of which did bring some damage to downtown Washington. And now these business leaders are saying they'd rather not make the risk again.

15:33Brian. Yes, I'll pray for peace, whatever the outcome. Megan Gosella, thank you very much. All right, we are going to take a very short break, but we've got more Fast Money coming up on deck. A trifecta of breaking news on semiconductors, slot machines, and some very private pills. Plus, what the government just did that melted down some of the red-hot nuclear names. That's all next.

16:02You're watching Fast Money here on CNBC. We'll be right back.

16:19We promised you earnings and we are delivering on our promises. We've got an earnings alert on NXP Semiconductor. that stock down a little bit, about 5.5 % on results. So let's find out why the stock is moving with Siva Modi. Hey, Brian, NXP Semiconductor shares declining after CEO Kurt Seaver said macro weakness in Europe and the Americas resulted in downbeat guidance for the fourth quarter. The health of its automotive business was in question following negative comments from Texas Instruments and On Semiconductor, but NXP managed to deliver revenues for autos that were in line with the street.

16:53The company does also have notable exposure to China about 35 percent of total revenue, according to Morgan Stanley. Regardless of who wins the election, Bank of America analysts expect restrictions on China to increase, which they say will challenge the entire semiconductor sector. A potential talking point on NXP's earnings call tomorrow. We'll also get an update from Supermicro after the bell, Brian. Waiting for Supermicro because that's not been a subject of trader discussion. Seema Modi, thank you very much. Let's talk about NXP semiconductor. Anybody here, I should know, But, you know, I don't I don't do this every day, Courtney.

17:27Anybody got a take on NXPI? The stock's kind of been dead money for about nine months in a market that's done pretty well. Yeah. And I think they're they're really going to be focused on the auto industry, which is really up for the debate with the election right now. Right. Because depending on where who's in office and what tariffs are going to be in place, that is going to affect the industry. Plus, we're seeing those longer term rates which are rising. And a lot of the auto industry, you're going to see more or less people will buy autos if those rates are going to be higher, if you're going to be paying more for your auto loan.

17:54So I think this is something that it's kind of one of those wait and see until after the election. Again, I don't always think that's what you should do. But in something that's so directly affected by that, I think you're going to see that. Well, you know, I would say I misspoke, but then I'd have to admit a mistake, which I'll never do. So if you expand the chart, it has been dead money for a couple of months, Carter. But if I expand that chart out, if we could throw a five-year chart of NXPI up, it's been dead money for three years. I mean, it's been a poor performer to its peer group, right, to semis.

18:19But I think the condition here is not one that's idiosyncratic. It's the whole space. We know that the semiconductor index relative performance peaked in March to the tech sector. So the most important part of the sector, semis, the most dynamic, its performance to its peer group, that would be Apple and Microsoft, peaked in March. And it's getting worse. The equal weight semiconductor has not made a new high since July. The semis have not made new highs since July. The market has made new highs. This whole area is all the elements of distribution. And in the auto industry, they rely as a percent of revenues.

18:52It's 55 percent, to Courtney's point. So autos are the chunk that have to do well, and they haven't done well enough for NXPI to thrive. You know, it's interesting. Just a quick side note. Did this election road trip two weeks ago. We drove across 900 miles. I talked to numerous business owners. They all said. I had no idea you were running. Did you know he was running? Not yet. He should run. You'll see. But a couple business owners told us that their business had kind of frozen up ahead of the election. that they almost felt like their customer base was just frightened in action. And I do wonder if after I bring this up because you wonder if somebody got to buy a car a couple of weeks before this election, when everyone's kind of on edge, could we see this business boom once it's once we have a clear winner, we move on.

19:36Could we have a business boom post-election, Steve? I wonder. It's always a possibility and you never know how the offsets shake out. You don't know who's coming in and what incentives are, but you need lower rates for the housing industry and you need lower rates for second mortgages and you need lower rates for auto loans. Yeah, I just it could be a good I'm trying to be optimistic on the election where once it's over, whether that's in a day or a week or a month, whatever it might be, that people are unfrozen from whatever concern they may have. And they go out and buy more cars. Maybe that benefits an NXPI.

20:09They do whatever it might take. And I just to put a bow on this whole underperformance of even three years, if you think about the industrial space, I mean, the industrial space was under a lot of pressure, supply chain dynamics during covid. That that meant there was not delivery of, you know, I mean, the chip dynamic for some of the autos was a big deal during late 21 and 22. And when demand has started to recover, it's why also I just think industrials as a group. And this may speak to kind of the dynamic you're talking about what we've seen with a handful. and I do mean GM, and I do mean even the airlines, we're seeing this part of the industrial sector start to break out after a long period of consolidation hire.

20:45Well said. All right, NXPI, a name that has not done a whole lot. All right, coming up here on Fast Money, more after-hours action on Palantir and Wynn results. Contessa Brewer is going to bring us the latest on Wynn and why investors do not like what they see. Plus, Amazon's nuclear no-go. So you got the federal government saying, uh-uh, Amazon and some big nuclear stocks took a hit because of it. That's all I have.

21:26All right, welcome back. Are the chips down at Wynn Resorts? Some investors apparently folding on the back of results. But there's always more to that. story, and I'll stop with the puns. The conference call just wrapping up. Contessa Brewer has the very latest. I knew you'd like it. I did it for you, Contessa. But what seems to have investors a little concerned? Well, you're watching the stock dropped about 4 % during the earnings call, despite CEO Craig Billings saying, look, everything's fine. Earnings missed. Revenue came in just shy. Adjusted property EBITDA, that's a crucial earnings metric, a little light.

22:00CEO Craig Billings said Golden Week in Macau, though, was great, encouraging that Wynn's market share in Macau is stable. Gross gaming revenue was down across the whole destination. You can't help that. And the other thing is we know that there was some ADR, the average daily room rates that had dropped somewhat in Macau, but they were running at almost 100 percent occupancy. On China stimulus, Billings says it's just a little bit too early to say whether that's driving visitation and spending. in Las Vegas. We saw the casino numbers softer than they were last year. It seems like Wynn was hit by a string of bad luck that we heard much of the, like other casinos on the strip, we've heard in their quarterly earnings reports as well.

22:44Billings described demand as healthy. He said that business from high-end customers is stable, but the year-on-year comparisons are tough. In fact, he says, look, in retail, we saw revenue up 3.5 % year-on-year. That's just an indication that customers are still spending on luxury. The other thing that they wanted to focus on was this board buyback. The board authorized about$750 billion of new buybacks. That brings the total to about a billion dollars. They said, all systems are go. I quote here, Brian, he said at the beginning of the call, look, trees don't grow to the sky, meaning there's a cap now and then to how much you grow.

Read the full transcript

23:23Trees also get cut down. They burn down. Get hit by lightning. They get hit by birds nesting them. Things happen. And we could go. We'll find out. But did it sound like business was OK, Contessa? Yes. Was it is it doing OK? Yeah. I mean, I mean, he says that everywhere that you look, Las Vegas, Boston actually beat the EBITDA estimates. It was the only destination that Wynn is in that did that, that that the demand is still healthy and that they're looking out toward 2025 and look like all systems are go. So there was no big problems to speak of. Again, they're talking about the future as being very bright, and especially because they're investing heavily in Almarjan Island in the UAE.

24:03This is going to be the first integrated resort in the Middle East, and they're putting a lot of chips in that basket. Or is it eggs? I see what you did there as well. It's a Syracuse grad for you. Tessa Brewer, thank you very much. Tim? Well, I think with Wynn and certainly other names that have a lot of exposure to Macau, like Las Vegas Sands, there's a story of where Macau is going to be uneven. But I think the longer picture here and the thesis for owning Wynn and Las Vegas Sands is that I think if your view is one to two years and beyond, then I realize it's been a long one year, even one and a half years, after these stocks actually had a fantastic late 2022 into 23 before giving a lot of that back.

24:45I like Vegas Sands, but I look at Wynn and I say four and a half times EBITDA. Talk about intrinsic value. It's there. It's there in these names, and it's not going to happen overnight. But I think the long term on the U.S. properties is normalization. And Macau is just recovery, and I expect it. And when you look at it, it was Vegas, Macau. Then you had Singapore with Las Vegas Sands. And now you have UAE. It's Boston property. Boston property, but you have UAE. I like that ability to throw that out there for future growth potential. So this would be my favorite name if I have to go with a traditional casino.

25:20There's always a shiny new thing, though, right? It was Macau. Then it was Boston. To your point, then it was Singapore. Now it's the UAE. How do the charts look? Over time. Look, this is a stock that peaked at$250 a decade ago. It's turned down 61%. It's a gambling chip. No pun intended. But you've got to catch it and trade it. And that's it. It's not an investment. I mean, it is an investment. It's something that whips around. It's the same level it was 14, 15 years ago. So you own it while you're buying a dividend? You're buying it as a cash flow fight? No, you're paying it for a trade because you think you're going to beat the earnings So someone's going to upgrade it or they'll put an article in Barron's about it and you catch it for three bucks and you get out.

25:52So cynical. I don't really is. I mean, it's like, you know. I'm surprised you didn't just use the term funny mentals because that's what Carter likes to do when he talks about it. But he's right on where you've been on the stock. But this has clearly been a trading stock. And I think there's a one to two year trade back to normalized valuations even. Trades clearly been a circus. Circus. All right. Coming up. Shares of Viking. Therapeutic. Shedding some pounds. by largely positive news on its weight loss drug efforts. So the stock is down. The news was OK, but there's some analyst discussion. We're going to put this all together and make sense of it for you coming up.

26:29But first, Amazon wanted a big nuclear push. But guess what? The U.S. government saying not so fast. We're going to find out what happened and the stocks it hit coming up. Missed a moment of fast? Catch us anytime on the go. Follow the Fast Money podcast. We're back right after this.

26:54All right. Stocks are dropping all ahead of tomorrow's presidential election. The Dow finishing down about 258 points. Not a lot. Six tenths of one percent. The S &P off 16. The Nasdaq down a third of one percent. Markets a little bit. Let's be clear. They've had a nice run. Little little sell off, little pullback today. ahead of the election. No shocker. Inside the market, you did have some movers. OK, Peloton, Peloton up about three and a half percent. Bank of America upgrading the stock to a buy from an underperform, saying it does see a little bit of earnings growth ahead for Peloton. But that stock's been absolutely leveled.

27:30In the meantime, Trump media, the ever volatile DJT, and I'm talking about the stock, snapping a three day losing streak that took 41 percent off the stock. It 12 percent. So it was up huge, down 41 percent, up another 12 percent. Dollar Tree jumping after hours. They had a C-suite shakeup. The COO, Michael Creighton Jr., will serve as the interim CEO as their current CEO steps down due to health issues. Finally, Palantir surging after hours thanks to a top and bottom line beat. Software company trading at all time highs and it's soaring right now. A lot of momentum behind that stock. It's up 12 percent.

28:08Not a lot of momentum today around nuclear-related names. It's because FERC, the Federal Energy Regulatory Commission, came out and basically denied Amazon's ability to make a nuclear deal with a company called Talon Energy. And that sent people running from the nuclear space in general. It's a pretty fairly complicated story. Let's figure it out with Pippa Stevens. Pippa. Hey, Brian. Well, so the FERC rejecting Talon's proposal, as you said, to increase the amount of power from the Susquehanna nuclear plant that would power a co-located Amazon data center. Now, it's what the industry calls behind the meter, meaning the data center would not pay for transmission and distribution costs.

28:53And some electric utilities in the region have said that will unfairly shift costs onto other consumers. Now, in addition to Talon, Vistra, Constellation, Public Service, Enterprise Group, Oclo and Newscale all fell on the regulators' decision. But multiple firms said to buy the dip, including UBS, which said, quote, investors should focus on the strong fundamental backdrop for Talon and the IPPs broadly and see through the noise created by the FERC ruling. Now, taking a step back, the data center theme has really exploded when power demand was already rising. And so stakeholders are trying to figure out how contracts should be structured.

29:30Or as Reeves Asset Management's John Bartlett told me, regulators want to make sure they're getting the cost allocation correct. And of course, Brian, this was the first agreement of its type and definitely not the last. Yeah, kind of scared everybody off. Everybody had these nuclear hopes. Pippa, then here comes FERC riding in. Pippa Stevens, really appreciate it. Thank you. Let's talk about this. It's one day. It's one decision. It doesn't take it all. But to Pippa's Point, Constellation, which is hoping to restart, they call it TMI now, Three Mile Island. This is a blow, Tim, I think. It's a roadblock, though.

30:03It doesn't stop the demand that's going on out there, not only for the grid, the power dynamic that's around data center and AI, but obviously the story that was nuclear power even without the data center and all of the demand that's come from also the hyperscalers and all these deals. Microsoft did their deal. They're all doing them or trying to do them. They will find their sources. But it doesn't really speak to what has been flowing for a long time. I mean, you asked the DOE, you know this. I mean, Jennifer Granholm thinks nuclear is the answer. We've changed the perception in this country of what nuclear can be.

30:35And I think the volatility in this trade, if you're playing nuclear, expect a lot more of it. But if you look at the five-year trend on this trade, it's your friend and it will continue to be. And that's critical, I think, to Tim's point. I want to make this clear, and Pippa made it clear as well, which is they don't – FERC is not being anti-nuclear here. What they're doing is they want the nuclear power to go to homes and buildings. They don't want private companies like Amazon to take it. Right. Microsoft wants to turn on three miles. They can take that energy. I think FERC's role and I can't speak for him, but it's pretty obvious is still pro nuclear.

31:09They just want it to be for towns, not to Tim's point. It's a bipartisan effort. Everyone's in favor of nuclear. power now. But I think the adoption is going to be from large cap tech at first before people get used to it. So that's going to put a roadblock. What does the relationship look like for a Google, for an Apple, for an Amazon and nuclear power? We've got to decide on that first. And maybe it's contractually locking up these companies. So it's not a physical, but it's those digital agreements that they'll have whenever FERC figures it out. Maybe this is going to be a presidential thing as well.

31:49I didn't want to go there, but I think you're exactly right. Maybe it'll be a deregulatory push. If there's a change in the regulatory schema for energy, maybe we get a reversal of a decision like this because the market was scared. They did a Constellation, which has been a red-hot stock, right? Go Baltimore. They won't be able to do the Three Mile Island deal. So maybe if this is I think energy, as much as any group without getting into the politics, Courtney, is a political play a little bit. It absolutely is. And I think at the end of the day, there's not enough electricity to go around specifically when it relates to A.I.

32:24And these large cap tech companies, they have this dual mandate where they need the energy, but also they're trying to get more clean and more environmentally friendly. And that's why nuclear is such a perfect answer for them. So I don't think some of these regulations are going to get in their way. Yes. Might it cost more for them? Might they have to fund some of these sources so that it does get to towns and it kind of gets with the government likes? probably. We're going to find somewhere in the middle, but I don't think this is going anywhere. I do think it's a buy-the-dip opportunity. Microsoft was willing to pay$100 a megawatt for electricity, which, if you don't know what that means, that's like four times the going.

32:52I saw Back to the Future. That's 1.72 gigawatts or whatever that was to get the DeLorean. All right. By the way, do not miss CNBC's special election coverage all tomorrow night. We're going to have all the results as they come in. Reaction from some of the biggest names in business. We start our coverage. By the way, This is fact-based. This is nonpartisan. We're looking at the markets, looking at the market reaction. 7 p.m. at the NYSE. Those results rolling in. I'm honored to be co-hosting the midnight to 5 a.m. I think that's when the action is going to be. We've got the coffee ready, Tim. Yeah, I'll be there.

33:24You'll be joining us? Everyone will be there, Brian. That's really a thing. Midnight to 5 a.m. That's when it's all going to happen, big boy. You thought this is going to be serious? Squawk Fox will pick up the large coverage. Call in. Steve, you're welcome. Our politics are the markets. That's it. That's it. Markets, markets, markets. All right. Coming in. Biotech Viking Therapeutics more than reversing earlier gains in the day down. Wow. 13 percent. We're going to talk about what exactly had that stock sort of whipsawing. Mizuho's Jared Holes will join us to help dig into the new weight loss drug data that is moving the stock.

33:57Did the market get it wrong? We're back after this.

34:08all right welcome back let's talk about viking therapeutics i know that's sort of big trader stock all right the stock fell today 13 it was up eight percent in the morning because there was some what some considered positive weight loss drug news on vikings patients on vikings oral drug losing a placebo-adjusted average of 6.8 % of their body weight on the highest dose at four weeks. But then the stock sold off. So let's figure out what's going on here. Jared Holes is healthcare sector strategist at Mizuho. And Jared, you argue that overall the news was actually pretty good on Viking. Ryan, thanks for having me.

34:48I appreciate it. Yeah, I think on the surface the data were good. I mean, it was kind of a reiteration of what the company had said about this program over the past couple of weeks. And the stock had done really, really well coming into this medical meeting that they're having now where that, you know, where more data kind of came out. But I think the fact that the stock had been on a nice run. And then on the flip side, there's so much more competitive data out there. AstraZeneca had some oral data. I think that was a contributing factor to the weakness today. And then as soon as we have anything good in health care, you know, investors kind of look at the negative side of the equation as well.

35:24You know, a lot of costs with respect to development and manufacturing and the competitive landscape is obviously very strong here, too. So I think all those things were factors today. So, Jared, when you look at this, just give us the gameplay for the average trader. When it first started, you had Lilly, then you had Novo, and now it's Viking, Amgen, and you just named a couple of other names as well. How does the person who's six degrees of separation or maybe three degrees of separation away from this trade the space? Steve, I don't know, actually. It's a great question. I mean, this is a game of leapfrog, it seems, not in perpetuity, but at least over the next couple of years.

36:06I think you've got to have, you know, from a trading standpoint, I think you've got to have one lead horse that you go with. That could be Lilly. That could be Novo, depending on the day, depending on valuation, depending on what the catalyst path looks like. So one of those, I think, is probably worth owning kind of at all times because they're the market leaders and will be for a while. And then I think you've got to just go down cap and find a couple of players that you believe might be instrumental over the long term. So a Viking, a Structure, a Terns, an Altimmune, a Corbis. There's a bunch of these kind of much smaller players in biotech.

36:44So pick a couple of those. I mean, Viking might be one of them. You know, maybe you get lucky with data or an acquisition. But I think you've got to have one lead horse and then maybe a couple of these smaller cap biotech stocks to own. So, Jared, in terms of the day-to-day action, we know it had earnings on the 24th and it popped essentially from 60 to 80. and now we've retraced that entire move. And there's two types of weakness, weakness to take advantage of and weakness to stay away from. Would you buy into this weakness or would you stay away from it? Yeah, Carter, I think you buy it. You know, this is still one of the better obesity names in the category.

37:20The data that they've shown have been excellent. We're in a little bit of a news vacuum as they move forward here into a larger phase two trial and try to get this drug, you know, on the market kind of sometime in the 2028-29 timeframe. So there's a lot of time in between. But look at what's happened to the valuation of the bigger players here. They've exploded. And so a$7 billion cap for what could be, you know, maybe the third drug in this class is probably a buy here. So, Jared, what happens then if Merck comes in and buys Viking? And again, I have actually a position of Viking, so disclose on that.

38:00But it seems to me this outrageous move you've seen in Novo and Lilly, at some point, more competitors of scale means that this two-horse race is something that I think, and you could make an argument on the charts. Maybe Carter's got to view when we're done here. But those are charts that have broken down or at least don't have the same gusto. So, again, Merck steps in as a distant number three with Viking closing the gap. Isn't that bad for the whole space, valuation-wise? Yeah, Tim, I don't know. I mean, some of that depends on, you know, if a Merck or another company were to come in here for Viking, what they pay for it.

38:36You know, Vikings talked about partnerships in the past. Maybe you get a joint venture. You don't get a straight takeout. But let's just assume it does get bought. I mean, if it's a if it's a double from here, if Merck decides that they want to pay 15 billion for the company outright and then put in, you know, the time and resources into manufacturing and commercializing this product. Does it cap the space? I would argue that probably be pretty good for a number of the smaller players. I mean, I think Lillian Novo would probably be down on that news because you would have, you know, a much bigger company marketing the drug.

39:10So I'd be more wary of owning Eli Lilly or Novo on that than I would owning biotech. I think, you know, for a takeout situation like you're calling for, you know, it's tough to make a bearish case on biotech. I'd be just more leery on pharma. Yeah, Jared Holtz, thank you for making some sense. I know some people out there were a bit confused. We appreciate it. All right, coming up, golden gains or hi-ho silver with the chart master right here. Seizing the technicals of the precious metal trade.

39:48All right, welcome back to Fast Money. Many gold miners hitting a key tactical level, Carter Ward says, down to the golden penny. With a copper penny. Well, that was the thing. When you speak of currencies, there was that expression, put more copper in the coinage. Oh, that means a little less silver, a little more copper. Right. It's called inflation in a different way. Anyway, let's get to it. So the uncontested winner this year is precious metals. Everyone knows it. Let's just put it up on the screen and see it in sort of black and white. Year-to-date, you've got silver. Behind that is gold.

40:24Behind that is the S &P. Behind that is Qs. And, of course, bringing up the rear, feebly is small cap IWM. But it's right on top silver. The beta trade within precious metals, gold behind it. Two comparative charts. This is a five-year comparative chart of GLD versus GDX, the metal versus the miners. They are dead even and actually 120 % even. five years. Now, of course, the long-term story is much different. If you look at the Philadelphia gold and miners stocks index versus the metal, you've got to blow away. And that either is the problem or the opportunity. Do you play the miners here for the real long-term catch-up?

41:05Finally, let's look at GDX. This is the instrument you can trade. Chart one of two. They're both identical. Very orderly drawdown, six of them, all about two weeks in duration, all about 9%, 10 percent. Second iteration of this chart, we are down to the penny, to that well-defined uptrend line in effect all year. Buy it for a bounce. That's my thought. Final chart, look at gold miners, gold mining stocks relative to stocks. This is a ratio chart. It depicts GDX relative to SPY. It gives you a relative strength line, a relative performance. We are making a turn. I'm a buyer of GDX. And I completely agree with you here.

41:41Just to go back even to one of our earlier conversations when we're looking at the longer term treasuries rising because everybody's expecting that inflation may start to kick in here again. That's where gold actually can be well positioned, especially your gold miners, I think, are not necessarily following that trend. It's absolutely something you want to take advantage of. And also, interestingly, of course, with this dollar strength, gold is held up like a rock. Very important. All right. Copper worth. That was great. Thank you very much. It is your final trades.

42:21All right, final trade time. Tim Seymour, your vote, and why don't you know who Michael Buble is? Yeah, I'm voting for you, Brian, as a fill-in. You're always top of the charts here. But Palantir also is top of the charts in terms of AI plays this year that have done well. Big numbers tonight. Courtney. Constellation Energy. We talked a lot about what was going on in the nuclear space. Think you want to buy that dip. Carter. Coal miners, GDX will get you done. After that segment, you had to say that, Steve. Roku, big dip on earnings. I'm looking for a bounce. It's a trade. It's not an investment.

42:51Wow, we ended so early. I know, yeah. Anyway, good stuff here is a great show. Thanks for taking it easy on the last few days. Mel will be back. We got, by the way, the election. Everybody out there, peace. All right, Mad Money with Jim Cramer begins right now. All opinions expressed by the Fast Money participants are solely their opinions and do not reflect the opinions of CNBC, NBCUniversal, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet, or another medium. You should not treat any opinion expressed on this podcast as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.

43:29Such opinions are based upon information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. To view the full Fast Money Disclaimer, please visit cnbc.com forward slash Fast Money Disclaimer.

From the publisher

Warren Buffett’s Berkshire Hathaway slashing its positions in a number of big names. So Is the Oracle of Omaha’s recent moves a warning sign for where these stocks are heading? Plus The pill that’s getting easier to swallow…  as Viking Therapeutics announces new data on its weight loss drug. The impact on the space, and why the stock reversed course from its initial jump.

Fast Money Disclaimer


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More from CNBC's "Fast Money"

All 872 episodes
Berkshire’s Cash Bulk… And New Data In The Weight Loss Drug Race 11/4/24CNBC's "Fast Money" · 44 min
Listen in VO